News | ASTRO | November 03, 2023

ASTRO recently issued the following statement on the Nov. 2 2024 Medicare PFS final rule, which includes an additional 2% cut for radiation therapy

ASTRO recently issued the following statement on the Nov. 2 2024 Medicare PFS final rule, which includes an additional 2% cut for radiation therapy

Getty Images


November 3, 2023 —The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M. Michalski, MD, MBA, FASTRO, Chair of the ASTRO Board of Directors, in response to the final 2024 Medicare Physician Fee Schedule (MPFS) released today by the Centers for Medicare and Medicaid Services (CMS): 

“ASTRO is deeply disappointed that CMS finalized an additional 2% cut to reimbursement for radiation therapy in today’s MPFS final rule. The consistent decline in Medicare reimbursement for radiation oncology threatens to undermine patients’ access to vital cancer care across the country. The time has come for Congress to intervene with reform legislation to ensure short-term stability and long-term viability. 

The additional cuts finalized today ensure that radiation oncology Medicare physician payments will have dropped by 25% from 2013 to 2024, more than nearly all other medical specialties. The continued trend of reduced reimbursement further underscores the critical need for a legislative fix for radiation oncology payments. 

Earlier this year, ASTRO introduced the Radiation Oncology Case Rate (ROCR) legislative proposal, a pivotal step toward ensuring that Americans have access to essential cancer care close to home. ROCR would create a new Medicare payment system for radiation oncology that is based on the value of the care provided, rather than the volume of services, offering an innovative path to achieving stable payments, enhancing the quality of care, reducing health disparities and lowering costs for both patients and Medicare. 

ASTRO also supports several legislative efforts designed to address shortcomings in the Medicare physician fee schedule, including: 

  • Providing Relief and Stability for Medicare Patients Act (H.R. 3674), introduced by Reps. Gus Bilirakis (R-FL), Tony Cardenas (D-CA), Greg Murphy, MD (R-NC) and Danny Davis (D-IL) to provide targeted relief to office-based specialists most effected by implementation of recent clinical labor price updates; 
  • Strengthening Medicare for Patients and Providers Act (H.R. 2474), introduced by Reps. Larry Bucshon, MD (R-IN), Raul Ruiz, MD (D-CA), Mariannette Miller-Meeks, MD (R-IA) and Ami Bera, MD (D-CA) to tie Medicare physician payment to inflation, as measured by the Medicare Economic Index; and 
  • Provider Reimbursement Stability Act (discussion draft), released by the GOP Doctors Caucus to update the MPFS budget neutrality threshold, address budget neutrality corrections for overestimates and underestimates in utilization, provide timely updates in direct costs used to calculate practice expenses and limit year-to-year variation in the physician payment conversion factor. 

ASTRO is determined to work Congress and CMS to secure the long-term stability needed for radiation oncologists to continue to deliver cutting-edge cancer care and maintain a strong focus on the value that we provide to our patients.” 

For more information: www.astro.org 


Related Content

News | Radiology Education

May 24, 2024 — The American Society of Radiologic Technologists (ASRT) has announced that its ASRT Foundation has ...

Time May 24, 2024
arrow
News | Enterprise Imaging

May 24, 2024 — International medical imaging IT and cybersecurity company Sectra’s enterprise imaging solution has been ...

Time May 24, 2024
arrow
News | Artificial Intelligence

May 23, 2024 — NewVue.ai, born from the radiology technology pioneers behind peerVue and recognized as a trailblazer in ...

Time May 23, 2024
arrow
News | Radiation Therapy

May 23, 2024 — RaySearch Laboratories AB and C-RAD announced a collaboration agreement, aiming at jointly developing ...

Time May 23, 2024
arrow
News | FDA

May 22, 2024 — The U.S. Food and Drug Administration (FDA) has issued a recall of the Hologic Inc. BioZorb marker due to ...

Time May 22, 2024
arrow
News | Artificial Intelligence

May 22, 2024 — Lunit, a provider of Artificial intelligence (AI)-powered solutions for cancer diagnostics and ...

Time May 22, 2024
arrow
News | Artificial Intelligence

May 22, 2024 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, recently ...

Time May 22, 2024
arrow
News | Oncology Information Management Systems (OIMS)

May 21, 2024 — RaySearch Laboratories AB announced that the oncology information system RayCare* 2024A has been ...

Time May 21, 2024
arrow
News | Proton Therapy

May 21, 2024 — IBA, a world leader in particle accelerator technology, announced that it has signed a contract with the ...

Time May 21, 2024
arrow
News | Radiology Business

May 20, 2024 — Associated Medical Professionals of NY (A.M.P.) announced that internationally recognized radiation ...

Time May 20, 2024
arrow
Subscribe Now